Valeant shares slide despite CEO's return after long illness
Monday, February 29, 2016 - 10:50
in Mathematics & Economics
Shares of Valeant Pharmaceuticals are down sharply in morning trading Monday, amid ongoing turmoil over the embattled drugmaker's delayed financial results and its leader's health....